↓ Skip to main content

Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia

Overview of attention for article published in BMC Cancer, November 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia
Published in
BMC Cancer, November 2013
DOI 10.1186/1471-2407-13-547
Pubmed ID
Authors

Didier Kamioner, Stefan Fruehauf, Fréderic Maloisel, Laurent Cals, Stéphane Lepretre, Christian Berthou

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 17%
Student > Bachelor 4 14%
Researcher 3 10%
Other 2 7%
Student > Ph. D. Student 2 7%
Other 4 14%
Unknown 9 31%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 17%
Medicine and Dentistry 5 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Nursing and Health Professions 2 7%
Biochemistry, Genetics and Molecular Biology 2 7%
Other 2 7%
Unknown 11 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2013.
All research outputs
#20,433,667
of 22,986,950 outputs
Outputs from BMC Cancer
#6,527
of 8,353 outputs
Outputs of similar age
#163,576
of 188,415 outputs
Outputs of similar age from BMC Cancer
#89
of 105 outputs
Altmetric has tracked 22,986,950 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,353 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,415 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.